Meiji Yasuda America Inc Takes $3.82 Million Position in Corteva, Inc. $CTVA

by · The Cerbat Gem

Meiji Yasuda America Inc purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 56,998 shares of the company’s stock, valued at approximately $3,821,000.

Other hedge funds also recently modified their holdings of the company. JPL Wealth Management LLC acquired a new position in shares of Corteva during the 3rd quarter valued at $25,000. Redmont Wealth Advisors LLC acquired a new position in shares of Corteva in the 3rd quarter worth $29,000. Jackson Grant Investment Advisers Inc. grew its holdings in shares of Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after acquiring an additional 213 shares during the last quarter. Basepoint Wealth LLC acquired a new position in shares of Corteva in the 4th quarter worth $30,000. Finally, KERR FINANCIAL PLANNING Corp acquired a new position in shares of Corteva in the 3rd quarter worth $33,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Berenberg Bank lifted their target price on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a report on Thursday, March 26th. Zacks Research cut Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Citigroup lifted their target price on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Rothschild & Co Redburn lifted their target price on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Finally, Morgan Stanley lifted their target price on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Corteva has an average rating of “Moderate Buy” and an average target price of $88.81.

Read Our Latest Research Report on CTVA

Corteva Stock Performance

Shares of Corteva stock opened at $74.85 on Friday. The stock has a market cap of $50.06 billion, a PE ratio of 44.03, a price-to-earnings-growth ratio of 2.28 and a beta of 0.57. The business has a fifty day simple moving average of $80.54 and a 200-day simple moving average of $75.30. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63.

Corteva (NYSE:CTVA – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is 42.35%.

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Further Reading

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).